Chintagumpala, M., Terhune, C., Tong, L., Bouffet, E., Bartels, U., Fisher, M., … Gajjar, A. (2020). FACTORS ASSOCIATED WITH LONGER SURVIVAL AFTER FIRST RECURRENCE IN MEDULLOBLASTOMA BY MOLECULAR SUBGROUP AFTER RISK-BASED INITIAL THERAPY. In NEURO-ONCOLOGY (Vol. 22, pp. 394–394).

Chintagumpala, Murali, Colton Terhune, Lin Tong, Eric Bouffet, Ute Bartels, Michael Fisher, Tim Hassall, et al. “FACTORS ASSOCIATED WITH LONGER SURVIVAL AFTER FIRST RECURRENCE IN MEDULLOBLASTOMA BY MOLECULAR SUBGROUP AFTER RISK-BASED INITIAL THERAPY.” In NEURO-ONCOLOGY, 22:394–394, 2020.

Chintagumpala M, Terhune C, Tong L, Bouffet E, Bartels U, Fisher M, et al. FACTORS ASSOCIATED WITH LONGER SURVIVAL AFTER FIRST RECURRENCE IN MEDULLOBLASTOMA BY MOLECULAR SUBGROUP AFTER RISK-BASED INITIAL THERAPY. In: NEURO-ONCOLOGY. 2020. p. 394–394.

Chintagumpala, Murali, et al. “FACTORS ASSOCIATED WITH LONGER SURVIVAL AFTER FIRST RECURRENCE IN MEDULLOBLASTOMA BY MOLECULAR SUBGROUP AFTER RISK-BASED INITIAL THERAPY.” NEURO-ONCOLOGY, vol. 22, 2020, pp. 394–394.

Chintagumpala M, Terhune C, Tong L, Bouffet E, Bartels U, Fisher M, Hassall T, Gururangan S, Schroeder K, Hansford J, Quang DAK, Cohn R, Kellie S, McCowage G, Smith K, Northcott P, Robinson G, Gajjar A. FACTORS ASSOCIATED WITH LONGER SURVIVAL AFTER FIRST RECURRENCE IN MEDULLOBLASTOMA BY MOLECULAR SUBGROUP AFTER RISK-BASED INITIAL THERAPY. NEURO-ONCOLOGY. 2020. p. 394–394.